Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 211 entries
View as:

Different Radiation Dose With Concurrent Chemotherapy for Thoracic Esophageal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02850991 Org: User:
Start: 04/30/16 End: 04/30/22 Due: 04/30/23

Sorafenib Combined With Chemotherapy for Renal Collecting Duct Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01762150 Org: User:
Start: 06/30/11 End: 06/30/18 Due: 06/30/19

The Efficacy and Safety of Liangxue Ointment in the Treatment of Hand-foot Syndrome Caused by VEGFR-TKI Drugs

Phase: N/A Priority: Normal
NCT ID: NCT06583369 Org: User:
Start: 03/25/24 End: 03/25/25 Due: 03/25/26

Trastuzumab(Henlius®) Combined With Pertuzumab(Perjeta®) and Chemotherapy in Chinese Patients With Her2-Positive Metastatic Breast Cancer Previously Treated With Trastuzumab

Phase: N/A Priority: Normal
NCT ID: NCT05188495 Org: User:
Start: 05/10/21 End: 12/10/23 Due: 12/10/24

RSYR for Fatigue Reduction in Cancer Fatigue Caused by Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT05229029 Org: User:
Start: 04/02/20 End: 06/30/24 Due: 06/30/25

Tislelizumab Consolidation Therapy After Radiotherapy or Sequential Chemoradiation in Locally Advanced NSCLC Patients

Phase: N/A Priority: Normal
NCT ID: NCT05758116 Org: User:
Start: 07/07/22 End: 07/07/26 Due: 07/07/27

Early Diagnosis of Therapy-associated Cardiotoxicity Basing on Multi-tracer Multimodality PET/MRI

Phase: N/A Priority: Normal
NCT ID: NCT04555642 Org: User:
Start: 09/15/20 End: 02/28/22 Due: 02/28/23

Clinical Study of Pabolizumab for Neoadjuvant Immunotherapy of Locally Advanced Microsatellite-unstable Gastric Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05816863 Org: User:
Start: 03/01/23 End: 03/01/24 Due: 03/01/25

A Phase II Study of Dexamethasone, Azacitidine, Pegaspargase and Tislelizumab Plus Radiotherapy for Patients With Stage I/II Extranodal NK/T-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT07000617 Org: User:
Start: 03/21/25 End: 12/31/28 Due: 12/31/29

Total Neoadjuvant Therapy Followed by 'Watch and Wait' Approach or Organ Preservation for Low-risk Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04405206 Org: User:
Start: 05/25/20 End: 12/30/23 Due: 12/30/24

Trastuzumab, Pyrotinib Combined With Dalpiciclib and Endocrine Therapy for HR +/HER2 + Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05577442 Org: User:
Start: 10/20/22 End: 10/20/24 Due: 10/20/25

Effect of Laparoscopy-Assisted Distal Gastrectomy for Locally Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02464215 Org: User:
Start: 03/01/14 End: 08/31/20 Due: 08/31/21

Niraparib Maintenance in HRD-Positive Advanced Ovarian Cancer Following Front-Line Chemotherapy + Bevacizumab

Phase: N/A Priority: Normal
NCT ID: NCT06141265 Org: User:
Start: 11/01/23 End: 09/30/27 Due: 09/30/28

Herombopag for the Prevention of Radio-chemotherapy Induced Thrombocytopenia in Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06745219 Org: User:
Start: 01/01/25 End: 07/30/25 Due: 07/30/26

Attitudes and Technical Maneuvers Regarding Enterostomy Management and Stoma Creation Among Surgeons

Phase: N/A Priority: Normal
NCT ID: NCT06735729 Org: User:
Start: 06/19/22 End: 07/15/22 Due: 07/15/23

A Trial on Contrast-enhanced Ultrasound Versus Conventional Ultrasound Guided Biopsy of Liver Neoplasms

Phase: N/A Priority: Normal
NCT ID: NCT02413437 Org: User:
Start: 04/30/15 End: 12/31/17 Due: 12/31/18

Total Neoadjuvant Treatment Plus SHR1210 for High-risk Rectal Cancer and Biomarker Screening Base on Neoantigen

Phase: N/A Priority: Normal
NCT ID: NCT04340401 Org: User:
Start: 05/25/20 End: 04/30/22 Due: 04/30/23

Toripalimab in Combination With Axitinib in Patients With Localized Mucosal Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT04180995 Org: User:
Start: 08/06/19 End: 12/30/22 Due: 12/30/23

JWCAR239 in Patients With B Cell Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT07024147 Org: User:
Start: 07/01/25 End: 07/01/30 Due: 07/01/31

18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Diffuse Large B-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02928861 Org: User:
Start: 10/31/16 End: 12/31/18 Due: 12/31/19

To Evaluate the Performance of HepaSphere Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy on Unresectable Colorectal Liver Metastases

Phase: N/A Priority: Normal
NCT ID: NCT05889325 Org: User:
Start: 07/01/23 End: 11/30/23 Due: 11/30/24

68Ga-grazytracer PET/CT of Tumor Responses to Immunotherapy

Phase: N/A Priority: Normal
NCT ID: NCT05000372 Org: User:
Start: 09/22/21 End: 05/31/24 Due: 05/31/25

68Ga-HSA PET/CT Imaging for Protein-losing Enteropathy

Phase: N/A Priority: Normal
NCT ID: NCT06716788 Org: User:
Start: 05/01/25 End: 05/31/26 Due: 05/31/27

The Role of TCM on ERAS of Rectal Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT04749381 Org: User:
Start: 09/28/20 End: 02/20/23 Due: 02/20/24

A Phase I Study to Assess the Safety and Efficacy of [225Ac]Ac-DOTATATE in Patients With SSTR+ GEP-Nens

Phase: N/A Priority: Normal
NCT ID: NCT06732505 Org: User:
Start: 09/29/24 End: 03/31/26 Due: 03/31/27